about
Antibody-Based Strategies to Prevent and Treat InfluenzaNeutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus proteinSexual transmission and prevention of the hepatitis viruses A-E and GSexually acquired hepatitis.Hepatitis A: old and new.Safety and effectiveness of the new inactivated hepatitis A virus vaccine.Travel vaccines and elderly persons: review of vaccines available in the United States.Sexually transmitted diseases treatment guidelines, 2015.Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more.Antigenic and immunogenic properties of recombinant hepatitis A virus 14S and 70S subviral particles.A simple and rapid Hepatitis A Virus (HAV) titration assay based on antibiotic resistance of infected cells: evaluation of the HAV neutralization potency of human immune globulin preparations.Recombinant hepatitis A virus antigen: improved production and utility in diagnostic immunoassays.Functional recombinant human anti-HAV antibody expressed in milk of transgenic mice.Clinical development of a new inactivated hepatitis A vaccine.Foodborne outbreak of hepatitis A, November 2007-January 2008, Austria.Solvent/detergent treatment does not alter the tolerance or uptake of human normal immunoglobulin for intramuscular injection.Safety and immunogenicity of an inactivated hepatitis A vaccine in children 2 to 5 years old.
P2860
Q26798520-B12CFE19-35BA-4447-9E6A-2CC225C09486Q27469558-89250D49-F9EC-47E9-8B8D-30097BCF5B8AQ27477933-2F1C9CEF-6699-46D2-AC21-1DA1CD6BB90CQ30843237-F14D5508-ECC8-4C97-B091-28A36B2D3FD4Q33930596-570C6825-E297-4D1E-BB89-09FE63534335Q34278232-B222703F-29FB-4149-A9BC-FA60F5B6D3E6Q34392982-F8030390-5897-475A-924B-6B505A45108FQ34479272-71BA92C8-BA58-4541-BB27-33263BE9ED8CQ34725773-4DC398C0-F039-4986-9C6A-5B57F74CFDF8Q36642150-1AD191E3-44FD-490A-9026-9C8AC756A181Q37052237-C42DFA23-BE30-482B-878E-EC89FAFE6ACDQ39554494-5A5592D0-2EFA-43B8-9E19-C42D5B9B3173Q40011772-5B3BF0CD-B9BD-4EC0-A21D-6F56E3F6447BQ41328514-0120AA54-5C2A-496F-B799-8704611D551FQ43365155-DC6E5828-BB41-4E1E-BC20-BD2090099BC1Q43671478-F263B3E3-53FD-4021-A574-555883BBFB90Q45235063-7D802D24-CC67-4295-9B8D-4BAB3D9C3752
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Immunoglobulin prophylaxis for hepatitis A.
@ast
Immunoglobulin prophylaxis for hepatitis A.
@en
type
label
Immunoglobulin prophylaxis for hepatitis A.
@ast
Immunoglobulin prophylaxis for hepatitis A.
@en
prefLabel
Immunoglobulin prophylaxis for hepatitis A.
@ast
Immunoglobulin prophylaxis for hepatitis A.
@en
P356
P1476
Immunoglobulin prophylaxis for hepatitis A.
@en
P2093
Stapleton JT
Winokur PL
P304
P356
10.1093/CLINIDS/14.2.580
P407
P577
1992-02-01T00:00:00Z